News

{{ window.visitor.corporateClient.name }}

Corporate solution

{{ window.visitor.ipAccess.corporateClient.name }}

{{ window.visitor.corporateClient.name }}
Welcome to our Corporate client solution

Here you can administrate your corporate solutions users.
Welcome to your subscription for Life Science Focus
Welcome to our Corporate client solution

Your IP is registered with the company mentioned above and provides access to Life Science Focus.

Click here to go to sign-up

Advertisement

Advertisement

Danish heart drug developer heads for Swedish stock market

People & Careers

AlzeCure CEO steps down – co-founder takes over

AstraZeneca considers move into cancer vaccines

Xbrane wins long-awaited FDA approval for eye drug biosimilar

New lung cancer combo shown to extend survival by eight months

Advertisement

Sponsored content

”Cybersecurity Is Patient Safety”

Interview

Early gene therapy offers hope for some ALS patients

Enhertu wins EU approval in early breast cancer

In Focus

How GLP-1 drugs are changing what we buy at the supermarket

Sponsored content News from our members

Aurevia

From regulatory requirements to clinical reality: putting clinical & performance evidence into focus

GBA Key2Compliance AB

AI in Medical Devices: Understanding the Review Process and Common Gaps

Aurevia

Upcoming Course: Quality Management System according to EN ISO 13485:2016 - in practice

GRUBER A/S

Let's connect at COMPAMED 2026 in Düsseldorf

OEM Automatic AB

Effektiv flödesmätning för vatten- och avloppssystem med FLUXUS WD

OEM Automatic AB

Smartare kvalitetskontroll med Zebra NS42 från OEM Automatic

Aurevia

QAdvis & Scandinavian CRO are now Aurevia

KNF Neuberger AB

Pumphuvudkonfiguration: Optimera flöde och vakuumprestanda

Aurevia

From innovation to compliance: Medtech Compliance Forum by Aurevia & RAPS explores health technology

Aurevia

Integrated Clinical and Regulatory Support for Oncology Trials

Carl Zeiss AB

Explore the ZEISS Innovation Summit 2026

Aurevia

Your UKRP Partner for Medical Device Market Access in the UK

See all announcements

J&J hails early prostate cancer data as “the best we have ever seen”

Advertisement

Medtech

Miris under pressure as sales fall – CEO steps down

Roche scores phase III win with lung cancer drug

Interview

Study finds key gut bacterium undetectable in one in three Swedish infants

Advertisement

People & Careers

Vitrolife appoints Elin Frostehav as new CEO

AstraZeneca’s ADC candidate beats expectations – new phase III data at ESMO

Advertisement

Lilly’s obesity ads on the underground cleared by watchdog

Advertisement

Advertisement

Interview

Denmark a leader in EU clinical trials: “We should never accept unnecessary delays”

Medtech

UK ends uncertainty over CE marking for medical devices

Spago plans stock market exit to facilitate fundraising

Advertisement

Pfizer job cuts reported at several manufacturing sites

Medtech

Inossia raises SEK 88m – targets US approval

Moderna plunged by double digits after study data leaked

Advertisement

EQT leads €9.6bn buyout of Qiagen

Advertisement

Yes please, I would like to receive Life Science Focuss newsletter Read cookie and data policy.

Yes please, I would like to receive marketing, offers, surveys, etc. from Life Science Focus Read cookie and data policy.

Advertisement Advertisement

BREAKING

{{ article.headline }}

0.063|